The global Immune Health Supplements Market size is expected to reach USD 132.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.3% from 2021 to 2028. The growing prevalence of various infectious diseases caused by several micro-organisms, such as bacteria, fungi, viruses, and parasites, coupled with the rising demand for supplements to increase the body's immune system, is expected to boost the immune health supplements adoption across the globe. Besides, increasing adoption of immunity-boosting products due to the COVID-19 pandemic is also anticipated to accelerate the market growth over the forecast years. According to the Council for Responsible Nutrition (CRN) report in 2020, the consumption of dietary supplements among Americans was about 73 percent. However, taking dietary supplements among individuals for immune health has been increased from 27 percent to 32 percent from 2019 to 2020.
As of 2020, the vitamin and mineral supplements
segment held the largest revenue share. The increasing adoption of vitamin C,
D, multivitamins, and minerals resulted in a high revenue share for the segment
in the market. An unhealthy diet limited physical activity, and a sedentary
lifestyle are the key factors responsible for increasing vitamin and mineral
intake to improve an individual's immunity, especially in the developed regions
such as North America and Europe. However, the increasing patient population
and growing awareness for vitamin and mineral consumption are the major factors
expected to boost market growth in emerging economies such as Asia Pacific and
Latin America during the forecast period. However, the herbal
supplements segment is also anticipated to be the second-largest product
segment due to its popularity for long-term consumption as immunity boosters
without any side effects.
By form, the tablets segment accounted for the largest
revenue share in 2020. Due to its longer shelf life and high preference of
adoption among the individual's tablets segment is expected to be the dominated
segment. Tablets are more stable than the capsule, particularly in moist
environments. In addition, tablets are largely manufactured by the key market
players than the other form of supplements. Further, properties of tablets such
as durability, inexpensive, can be split into two parts, and higher dosage
accommodation is anticipated its high adoption and maximum value share in the
market.
The respiratory tract infection segment held the
largest revenue share in 2020. Due to the increasing prevalence of respiratory
disorders such as COPD, asthma, COVID19, immune health supplements adoption has
increased in the last couple of years. Particularly, the rapid rise in
life-threatening coronavirus disease from the last year has increased the
adoption of immunity-boosting products to manage respiratory tract infections.
Taking supplements such as Vitamin C, D, and minerals such as zinc and
probiotics offers unique properties to reduce the risk of respiratory tract
infection, duration, and severity of infection.
As of 2020, the self-medication segment accounted for
the largest revenue share than the prescription-based segment. It can be
attributed due to the high percentage of self-medicated supplements using the
population around the globe. Further, most of the vitamins and mineral
supplements do not require a prescription. One can purchase them from
pharmacies, groceries, and any convenience stores. Besides, the growing
awareness among the individuals to use immunity-boosting products due to
COVID19 is also expected to provide a high market share to the self-medication
segment over the forecast years globally.
The pharmacies/drug stores segment dominated the
market and accounted for the largest revenue in 2020. The availability of a
wide variety of products and the high preference of consumers to buy immune
health supplements from pharmacies are the factors responsible for the largest
market share of this segment. Moreover, the availability of both prescriptions
based and over-the-counter products for the consumers is also expected to
accelerate the growth of the Pharmacies/drug stores segment over the forecast
years.
North America dominated the market and accounted for
the largest revenue share in 2020. The increasing prevalence of various health
disorders, increasing usage of immune-enhancing products, and high spending
capacity by the consumers are the factors anticipated to provide the majority
of market share to the region. However, Asia Pacific countries, such as China,
India, and Japan, are expected to witness significant growth over the forecast
years due to the large population, increasing awareness, and growing consumer
base in these countries.
Related Press Release@ Immune Health Supplements Market Report
Immune Health Supplements Market
Report Highlights
- The market is expected to grow well over the forecast period owing
to the increasing prevalence of several infectious diseases and growing
awareness to improve immune health
- The vitamin and mineral supplements segment dominated the market in
2020 owing to high demand and increasing use for immune health
- The respiratory tract infection application segment dominated the
market in 2020 owing to the increasing adoption of immune supplements to
reduce the risk of respiratory tract infection across the globe
- The self-medication segment dominated the market in 2020 majorly
due to a growing preference for self-medicated use of supplements than
prescription-based
- The pharmacies/drug stores segment dominated the market in 2020
owing to the availability of a wide range of products and high consumer
preference
- North America dominated the market in 2020 majorly due to high
spending capacity and increasing uses of immune health supplements in the
region
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment